AWM — Airway Medix SA Income Statement
0.000.00%
- PLN39.42m
- PLN51.93m
- PLN0.01m
Annual income statement for Airway Medix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
| 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 0.257 | 0 | 0.095 | 0.012 | 0.012 | 
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | -0.006 | 
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2.47 | 8.77 | 36.3 | 2.66 | 6.4 | 
| Operating Profit | -2.21 | -8.77 | -36.2 | -2.65 | -6.39 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.99 | -9.76 | -37.4 | -3.28 | -11.7 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.37 | -7.44 | -37.9 | -3.28 | -11.7 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.37 | -7.44 | -37.9 | -3.28 | -11.7 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.37 | -7.44 | -37.9 | -3.28 | -11.7 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.041 | -0.127 | -0.279 | -0.054 | -0.159 | 
| Dividends per Share |